XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Shares [Member]
Total Teva Shareholders' Equity [Member]
Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2020 $ 11,061 $ 57 $ 27,443 $ (10,946) $ (2,399) $ (4,128) $ 10,026 $ 1,035
Beginning balance, shares at Dec. 31, 2020   1,202            
Net Income (loss) 306     284     284 21
Other comprehensive income (loss) (115)       (47)   (47) (68)
Issuance of Shares, shares [1]   6            
Stock-based compensation expense 60   60       60  
Ending balance at Jun. 30, 2021 11,311 $ 57 27,503 (10,662) (2,446) (4,128) 10,324 987
Ending balance, shares at Jun. 30, 2021   1,209            
Beginning balance at Mar. 31, 2021 10,975 $ 57 27,474 (10,869) (2,534) (4,128) 10,000 975
Beginning balance, shares at Mar. 31, 2021   1,208            
Net Income (loss) 221     207     207 14
Other comprehensive income (loss) 87       88   88 (1)
Issuance of Shares, shares [1]   1            
Stock-based compensation expense 29   29       29  
Ending balance at Jun. 30, 2021 11,311 $ 57 27,503 (10,662) (2,446) (4,128) 10,324 987
Ending balance, shares at Jun. 30, 2021   1,209            
Beginning balance at Dec. 31, 2021 11,244 $ 57 27,561 (10,529) (2,683) (4,128) 10,278 966
Beginning balance, shares at Dec. 31, 2021   1,209            
Net Income (loss) (1,211)     (1,187)     (1,187) (24)
Other comprehensive income (loss) (268)       (118)   (118) (150)
Issuance of Shares, value 1   1       1  
Issuance of Shares, shares [1]   7            
Stock-based compensation expense 63   63       63  
Ending balance at Jun. 30, 2022 9,828 $ 57 27,625 (11,716) (2,801) (4,128) 9,037 791
Ending balance, shares at Jun. 30, 2022   1,216            
Beginning balance at Mar. 31, 2022 10,260 $ 57 27,587 (11,484) (2,687) (4,128) 9,344 916
Beginning balance, shares at Mar. 31, 2022   1,216            
Net Income (loss) (259)     (232)     (232) (27)
Other comprehensive income (loss) (212)       (114)   (114) (98)
Stock-based compensation expense 39   39       39  
Ending balance at Jun. 30, 2022 $ 9,828 $ 57 $ 27,625 $ (11,716) $ (2,801) $ (4,128) $ 9,037 $ 791
Ending balance, shares at Jun. 30, 2022   1,216            
[1] Represents an amount less than $0.5 million.